Physician profile
Kham V Ung
NPI 1205937554
$4,330.49
in general payments reported to CMS, 2019-2025
14 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,451 · 2020: $181 · 2021: $219 · 2022: $400 · 2023: $1,597 · 2024: $276 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,226 · Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,226.34 |
| Food and Beverage | $853.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,675.71 | 2019-2025 | Grafix, Stravix Pl, Oasis |
| Paragon 28, INC. | $1,012.73 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $220.15 | 2019 | |
| Solventum Corporation | $80.06 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Mimedx Group, INC. | $65.54 | 2024 | |
| Paratek Pharmaceuticals, INC. | $59.49 | 2024 | Nuzyra |
| Horizon Therapeutics Plc | $46.02 | 2019 | |
| Urgo Medical North America, LLC | $32.28 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Vertex Pharmaceuticals Incorporated | $29.16 | 2024 | |
| Merck Sharp & Dohme LLC | $26.78 | 2019 | |
| Biotissue Holdings INC. | $25.09 | 2023 | |
| Osiris Therapeutics INC. | $24.63 | 2019 | |
| Polynovo North America LLC | $18.38 | 2025 | Novosorb Btm |
| Kerecis Limited | $14.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kham Ung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.